Press releaseBusiness Wire
Roman DBDR Acquisition Corp. II
DRDBW · NASDAQ
$0.0969+$0.0012 (+1.25%)TodayMarket closed ·
Prev close $0.0957
DRDBW key statistics
- Market cap
- —
- Price-earnings ratio
- 0.00
- Dividend yield
- —
- Average volume
- 4.76K
- Volume
- 95
- Open price
- $0.0965
- High today
- $0.0969
- Low today
- $0.0876
- 52 Week high
- $0.8559
- 52 Week low
- $0.071
Roman DBDR Acquisition Corp. II (DRDBW) at a glance
Roman DBDR Acquisition Corp. II (DRDBW) last traded at $0.0969, with a price-to-earnings ratio of 0.00.
Today the stock has traded between $0.0876 and $0.0969. The current price is 10.6% above the day's low and 0.0% below its high.
Volume so far is 95 shares, below the average of 4.76K shares a day.
Over the past year Roman DBDR Acquisition Corp. II has ranged from $0.071 to $0.8559, and now sits 3% of the way up that range.
DRDBW news
Most active stocks
Highest trading volume today
- EARIEntertainment Arts Research$0.0002+0.00%
- GTVHGolden Triangle Ventures$0.0002+100.00%
- TMSHTrans Global Assets$0.0003+20.00%
- RDARRaadr$0.0002+0.00%
- GPUSHyperscale Data$0.1689+34.05%
- SEIISharing Economy International$0.0002−33.33%
- ELMEElme Communities$1.77+0.57%
- SHFSSHF Holdings$0.1324−61.39%
- XXII22nd Century Group$0.1977−8.34%
- NBNDNetBrands$0.0006−40.00%
- NVDGraniteShares ETF Trust$4.19+0.96%
- HIRUHiru$0.0006+9.09%
Newly listed
Companies that went public in the past six weeks
- TCXBTCGX Acquisition Corp. II$10.49−0.10%
- CTYCITY THERAPEUTICS$20.77+0.00%
- IAMIambic Therapeutics$14.26−2.79%
- AMROAmaero$5.84+7.75%
- FLSCFrazier Life Sciences Acquisition Corp. II$10.30+0.29%
- TRXBTRex Bio$13.81−10.90%
- RTSNRetension Pharmaceuticals$15.25−1.61%
- PAXGUPine Tree Acquisition$10.01+0.05%
- PORTUSouthport Acquisition Corp. IIListed Oct 1, 2026
- CHWMChilwa Minerals$5.13−0.77%
- ACCVAccelevation Holdings$12.38+1.06%
- RZAIROZE AI$10.92−1.89%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.